Cure51
The company assembles data about long term survivors of cancer, thus hoping to crack the code on what keeps people alive.
Cure51 has raised €15M across 1 funding round from 5 investors, most recently a Seed round in Mar 2024. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.cure51.com ↗
Total raised
€15M
€15,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2024-03
latest 2024-03
Funding by year
EUR raised per yearCure51 — funding by year — interactive chart.
Data table
| Cure51 — funding by year | |
|---|---|
| 2024 | €15M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-20 | Seed | €15M | Hitachi Ventures,Life Extension Ventures,Olivier Pomel,Sofinnova Partners,Xavier Niel | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData